Paper35501464
The microRNA-3622 family at the 8p21 locus exerts oncogenic effects by regulating the p53-downstream gene network in prostate cancer progression.
Zhang Y and 11 others. Oncogene, 2022. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. The microRNA-3622 family at the 8p21 locus exerts oncogenic effects by regulating the p53-downstream gene network in prostate cancer progression. Papers, record 35501464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35501464
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The microRNA-3622 family at the 8p21 locus exerts oncogenic effects by regulating the p53-downstream gene network in prostate cancer progression.
- PubMed
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Prostatic Neoplasms | Major topic |
| Carcinogenesis | |
| Cell Line, Tumor | |
| Cell Movement | |
| Cell Proliferation | |
| Chromosomes, Human, Pair 8 | |
| Gene Expression Regulation, Neoplastic | |
| Gene Regulatory Networks | |
| Humans | |
| Male | |
| Prostate | |
| Tumor Suppressor Protein p53 |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA013148 | NCI NIH HHS | United States | P30CA013148 | PubMed and NIH | NIH RePORTER |
| U54 CA118623 | NCI NIH HHS | United States | U54CA118623 | PubMed and NIH | NIH RePORTER |
| U54 CA118638 | NCI NIH HHS | United States | U54CA118638 | PubMed and NIH | NIH RePORTER |
| U54 CA118948 | NCI NIH HHS | United States | U54CA118948 | PubMed and NIH | NIH RePORTER |
References4
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27683484 | Prostate Cancer Genetics: A Review. | EJIFCC | 2015 | https://conductscience.org/library/papers/27683484 | PubMed |
| 2 | 7478532 | Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes. | Oncogene | 1995 | https://conductscience.org/library/papers/7478532 | PubMed |
| 3 | 21042716 | Establishment and characterization of a pair of non-malignant and malignant tumor derived cell lines from an African American prostate cancer patient. | Int J Oncol | 2010 | https://conductscience.org/library/papers/21042716 | PubMed |
| 4 | 32205365 | Fibrinogen Alpha Chain Knockout Promotes Tumor Growth and Metastasis through Integrin-AKT Signaling Pathway in Lung Cancer. | Mol Cancer Res | 2020 | https://conductscience.org/library/papers/32205365 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42253611 | CRISPR decodes the RNA regulatory network in prostate cancer: A review from mechanisms to precision therapeutics. | Noncoding RNA Res | 2026 | https://conductscience.org/library/papers/42253611 | PubMed |
| 41585137 | Apoptosis-inducing factor mitochondria-associated 2 (AIFM2) promotes tumor progression and predicts poor prognosis in oral squamous cell carcinoma. | J Dent Sci | 2026 | https://conductscience.org/library/papers/41585137 | PubMed |
| 41234971 | A Rare Case of Profound Pulmonary Venous Malformation in an Elderly Individual With Three Major Comorbidities: Genetic Insights. | Cureus | 2025 | https://conductscience.org/library/papers/41234971 | PubMed |
| 40862825 | Roles and Prospective Applications of Ferroptosis Suppressor Protein 1 (FSP1) in Malignant Tumor Treatment. | Curr Oncol | 2025 | https://conductscience.org/library/papers/40862825 | PubMed |
| 38615304 | FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications. | Apoptosis | 2024 | https://conductscience.org/library/papers/38615304 | PubMed |
| 38012214 | Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/38012214 | PubMed |
| 37443779 | Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers. | Cells | 2023 | https://conductscience.org/library/papers/37443779 | PubMed |
| 37256211 | Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/37256211 | PubMed |
Genes36
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35501464
GET https://conductscience.org/api/papers/v1/35501464/genes?page=2